Purpose Non-functioning pituitary adenomas (NFPAs) are benign pituitary neoplasms that
do not cause a hormonal hypersecretory syndrome. An improved understanding of their …

Objective Prolactin-secreting tumors respond well to medical management, with a few
patients requiring surgery. We conducted a systematic review and meta-analysis to study the …

Background: The prevalence rates of freezing of gait (FOG) in Parkinson's disease (PD) vary
widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in …

Aim Prolactinoma, a prolactin (PRL) secreting functioning pituitary tumor, is the most
common of all pituitary adenomas (PA) accounting for 40-60% and dopamine agonists (DA) …

Purpose Both prolactinomas and nonfunctioning adenomas (NFAs) can present with
hyperprolactinemia. Distinguishing them is critical because prolactinomas are effectively …

The metabolic syndrome (MetS) is a conglomerate of clinical findings that convey into
increased morbidity and mortality from type 2 diabetes mellitus (T2D) and cardiovascular …

Objective To investigate the clinical characteristics of hypopituitarism and its reversibility
after surgery for nonfunctional pituitary adenoma (NFPA); analyze the correlation between …

Background Primary lactotroph disinhibition, or stalk effect, occurs when mechanical
compression of the pituitary stalk disrupts the tonic inhibition by dopamine released by the …

Purpose Non-functioning pituitary adenomas (NFPAs) are often associated with
hyperprolactinemia, which is known as the “stalk effect”. However, the relationships between …

Objective Preoperative diagnosis of prolactinomas is critical because dopamine agonists
have been regarded as a primary treatment. However, serum prolactin level alone is …